II.
Review and Approval or the Agenda
III.
OPLC and/ or Board Administration Updates
2.
Commissioner Rochefort
3.
Commissioner Laliberte
4.
Commissioner Harrington
A.
Approval of the Minutes
1.
PIC Change-Rite Aid, Milford, Lic # 0121
2.
PIC Change-New England Life Care, Concord Lic # 0275
C.
Collaborative Practice
D.
Automated System Registration
1.
Merriman House, North Conway
1.
FDA Announces New FAQs Addressing Compounding Inspections and Oversight; Two On-Demand Webinars Addressing FDA Compounding Inspections
2.
FDA Issues Draft Guidance Addressing Prohibitions of Compounded Drug Wholesaling
3.
Open Executive Director Position – Oregon Board of Pharmacy
4.
Subscriptions for USP-NF and Compounding Compendium for Boards of Pharmacy
5.
Email Newsletter Report
6.
Pharmacy Workforce Summit Announcement
7.
National Advisory Council for the Agency for Healthcare Research and Quality
8.
DEA Response to Industry Inquiry Regarding Prescription Sales of Scheduled Listed Chemical Products
9.
DSCSA Webinar Series to Be Held for Regulators
10.
Intravenous Hydration Clinics: Federal and State Regulatory Perspectives
G.
Additional Consent Items
1.
Cheshire Controlled Substance Report
A.
Non-Disciplinary Hearing- 10:00am- Jacqueline H. Nguyen
B.
Non-Disciplinary Hearing- 9:30am- Melissa Ostrander
C.
Rite Aid, Pelham, Lic # 0545
VI.
Rules Review and Other Legislative Topics
A.
Public Hearing 9:30 a.m.- PH 200 initial proposal
B.
Ph 1000 Standards of Practice for Manufacturers, Wholesalers and Distributors
E.
Ph 2000 Inspection Reports
F.
Compounding Draft Rules
VII.
Licensure Approval (if applicable)
A.
James Phillips, Reinstatement
B.
Parkland Medical Center, Plaistow- Temporary Permit
C.
Pharmacy Remodel- Genoa, Nashua Lic # 0805
D.
New Application- FinVector Oy
E.
Lucy M. Hoff, Temp Pharmacist EL11910
F.
Cherie Ann Beando, Lic. # R2132
G.
Precision Compounding Pharmacy & Wellness, Inc, lic # NR2290
A.
NABP State Report- Dist.1 July 2023